MELISSA MOORE-COLVERT: Open Payments
NPI 1447555628 · ENID, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$491 in 18 payments from 9 companies in 2025. Trend: 2023 $587 · 2024 $482 · 2025 $491
Food & beverage: $491
| Company | Payments | Amount |
|---|---|---|
| Endologix LLC | 1 | $149 |
| Merck Sharp & Dohme LLC | 6 | $123 |
| Amgen Inc. | 3 | $59 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Kestra Medical Technology Services, Inc. | 1 | $42 |
| Tactile Systems Technology Inc | 1 | $17 |
| PFIZER INC. | 1 | $16 |
| Novo Nordisk Inc | 1 | $14 |
| Novartis Pharmaceuticals Corporation | 1 | $14 |
Products named: ENDOCROSS Device, VERQUVO, REPATHA, ELIQUIS, Assure WCD, CAMZYOS, Flexitouch Plus, Wegovy.
Industry payments across OK — which companies pay providers there.
